A recent study published in BMC Veterinary Research highlights the efficacy of OKV-119, a novel miniature drug implant, in reducing weight in obese cats. This implant, utilizing Vivani Medical’s NanoPortal technology, delivers exenatide for long-term weight management. Exenatide aids in regulating blood sugar levels and facilitating weight loss. The study demonstrated that cats implanted with OKV-119 experienced a significant reduction in weight compared to controls. The sustained release of exenatide over 84 days effectively curbed appetite and boosted energy expenditure, addressing feline obesity, a prevalent health issue affecting up to 40% of domestic cats. OKV-119's development is a promising advancement in combating feline obesity. Its convenient administration and prolonged effectivity present a groundbreaking solution to enhance feline health and combat associated conditions like diabetes, heart disease, and joint pain. Future research aims to extend the implant's duration to six months, further improving its practicality in long-term feline obesity treatment. Read more about this innovative solution in veterinary care: https://lnkd.in/dWfmBrch Adam Mendelsohn Linda Adreveno
Moe Alsumidaie’s Post
More Relevant Posts
-
Why is pancreatic lipase testing important? It can help veterinarians confidently diagnose pancreatitis in dogs and cats. Learn more in Natalie Marks, DVM, CVJ, CFCP, Elite FFCP-V recent Vetiverse article.
The Critical Role of Pancreatic Lipase Testing for Detecting Pancreatitis
thevetiverse.com
To view or add a comment, sign in
-
The Veterinary Diagnostic Laboratory continues to see substantial bovine abortion cases. As a reminder, in-house postmortem examinations of aborted fetuses have higher rates of agent recovery and identification compared to field performed necropsies. If an aborted fetus cannot be submitted to the NDSU VDL for pathologist examination, the following tissues are recommended for optimal results: • Fresh and formalin-fixed placenta • Whole fetus/neonate (recommended)or fresh and fixed tissues, including: —Fresh brain, heart, lung, liver, kidney, spleen, abomasal fluid, thymus, thyroid, lymph node, fetal eyeball/vitreous humor (for nitrate analysis), placenta and any tissue with a suspected lesion. — Formalin-fixed placenta, brain, thymus, heart, lung, liver, kidney, spleen, conjunctiva, adrenal gland, skeletal muscle and any tissue with a suspected lesion. • Feed and water • Maternal sera (acute and convalescent)
To view or add a comment, sign in
-
🐾 New Insights into Canine Atopic Dermatitis: A Comprehensive Study 🐾 A study titled "Canine Atopic Dermatitis: Prevalence, Impact, and Management Strategies," published on February 13, 2024, in the Veterinary Medicine: Research and Reports journal, considers the prevalence, impact, and complexities of managing Canine Atopic Dermatitis (CAD). Authored by Yvonne Drechsler, Charli Dong, David E. Clark, and Gagandeep Kaur from the College of Veterinary Medicine, Western University of Health Sciences, and the Animal Dermatology Clinic in Pasadena, this study emphasizes the challenging nature of CAD. STUDY FINDINGS: • PREVALENCE: The research highlights varying prevalence rates of CAD, influenced by genetic and environmental factors. • IMPACT ON QUALITY OF LIFE: The study discusses how CAD not only affects dogs but also significantly impacts the quality of life of their guardians, affecting everything from daily routines to emotional well-being. • MANAGEMENT STRATEGIES: The researchers propose a multimodal approach to managing CAD, focusing on a combination of topical and systemic therapies, lifestyle and dietary changes, and innovative treatments like immunotherapy. • INNOVATIVE TREATMENTS DISCUSSED: Immunotherapy: Highlighting its use since 1911, the study discusses the benefits and customization of Allergen-specific Immunotherapy (ASIT) for CAD. Biological Therapies: Exploration of new biological treatments, such as monoclonal antibodies targeting specific pathways involved in CAD, shows promising avenues for more targeted and effective management. Researchers discuss the necessity for veterinarians to adopt a comprehensive and personalized approach to managing CAD, considering the diverse clinical presentations and responses to treatment. Education for pet parents on the chronic nature of CAD and the importance of consistent treatment regimens is crucial for managing expectations and improving outcomes. For those dealing with CAD, this study provides useful insights and guidance. The full text offers detailed data and recommendations, available for further reading and application in clinical settings: https://lnkd.in/gq4bzyH8 This study advances our understanding and opens new pathways for the effective management of Canine Atopic Dermatitis. #CanineHealth #VeterinaryMedicine #AtopicDermatitis #DogCare #PetHealth, #VetMedResearch #InnovativeTreatments #VirginiaDogTrainer #DogTrainer #JoyfulDog
To view or add a comment, sign in
-
🐾 New Insights into Canine Atopic Dermatitis: A Comprehensive Study 🐾 A study titled "Canine Atopic Dermatitis: Prevalence, Impact, and Management Strategies," published on February 13, 2024, in the Veterinary Medicine: Research and Reports journal, considers the prevalence, impact, and complexities of managing Canine Atopic Dermatitis (CAD). Authored by Yvonne Drechsler, Charli Dong, David E. Clark, and Gagandeep Kaur from the College of Veterinary Medicine, Western University of Health Sciences, and the Animal Dermatology Clinic in Pasadena, this study emphasizes the challenging nature of CAD. STUDY FINDINGS: • PREVALENCE: The research highlights varying prevalence rates of CAD, influenced by genetic and environmental factors. • IMPACT ON QUALITY OF LIFE: The study discusses how CAD not only affects dogs but also significantly impacts the quality of life of their guardians, affecting everything from daily routines to emotional well-being. • MANAGEMENT STRATEGIES: The researchers propose a multimodal approach to managing CAD, focusing on a combination of topical and systemic therapies, lifestyle and dietary changes, and innovative treatments like immunotherapy. • INNOVATIVE TREATMENTS DISCUSSED: Immunotherapy: Highlighting its use since 1911, the study discusses the benefits and customization of Allergen-specific Immunotherapy (ASIT) for CAD. Biological Therapies: Exploration of new biological treatments, such as monoclonal antibodies targeting specific pathways involved in CAD, shows promising avenues for more targeted and effective management. Researchers discuss the necessity for veterinarians to adopt a comprehensive and personalized approach to managing CAD, considering the diverse clinical presentations and responses to treatment. Education for pet parents on the chronic nature of CAD and the importance of consistent treatment regimens is crucial for managing expectations and improving outcomes. For those dealing with CAD, this study provides useful insights and guidance. The full text offers detailed data and recommendations, available for further reading and application in clinical settings: https://lnkd.in/egqhz955 This study advances our understanding and opens new pathways for the effective management of Canine Atopic Dermatitis. #CanineHealth #VeterinaryMedicine #AtopicDermatitis #DogCare #PetHealth, #VetMedResearch #InnovativeTreatments #VirginiaDogTrainer #DogTrainer #JoyfulDog
To view or add a comment, sign in
-
Cheers to the CVM's Dr. Kate KuKanich, on joining seven other prominent, international feline pain-relief experts in publishing the "2024 ISFM and AAFP consensus guidelines on the long-term use of NSAIDs in cats." These guidelines present veterinary practitioners with decision-making tools for prescribing NSAIDs in situations of chronic pain to minimize adverse effects and optimize pain management for their feline patients. International Society of Feline Medicine American Association of Feline Practitioners (AAFP) Journal of Feline Medicine and Surgery https://lnkd.in/gYdA4ik6
K-State veterinarian collaborates on pain relief medication guidelines for cats
k-state.edu
To view or add a comment, sign in
-
Understanding the Difference Between Ejection Fraction (EF) and Fractional Shortening (FS) in Cats: A Clinical Perspective In veterinary cardiology, Ejection Fraction (EF) and Fractional Shortening (FS) are essential metrics for evaluating left ventricular systolic function in cats. While both measurements offer valuable insights, they differ in methodology and clinical implications. 🩺 Ejection Fraction (EF): EF is the percentage of blood volume ejected from the left ventricle with each contraction relative to its total volume at the end of diastole. EF is a more comprehensive indicator of systolic function because it reflects both the volume of blood pumped and the overall contractility of the myocardium. This makes EF particularly useful in assessing conditions like hypertrophic cardiomyopathy (HCM) where volumetric changes are critical. 🩺 Fractional Shortening (FS): FS measures the percentage reduction in the left ventricular internal diameter (LVID) from diastole to systole. While FS is easier to obtain and interpret, it primarily assesses myocardial contractility rather than volumetric changes. This can make FS less sensitive in detecting early or subtle changes in ventricular function, especially in cases with complex ventricular geometry. 🔍 Which is More Accurate? FS is often considered more accurate than EF in certain situations because it is less affected by variations in heart size and geometry. It provides a direct measure of the shortening of the left ventricular walls during contraction. As veterinarians, understanding the strengths and limitations of both EF and FS will enhance our ability to diagnose and manage feline cardiac conditions effectively.
To view or add a comment, sign in
-
🐈 Feline bacterial cystitis 🐈 I think we all know the clinical signs of a cat suffering from cystitis. The important part for us as veterinarians is to decide whether the cystitis requires antimicrobial treatment or not. As obvious as it may sound, if a urine sample has not been collected aseptically (ideally via cystocentesis), it is not considered optimal for bacteriology. However, in some instances, the use of sterile hydrophobic litter in a clean litter box might be a valid option for certain cats. Nevertheless, let's not forget the power of sediment examination in providing quick information. It is recommended to stain the slide for better observation of bacteria. Bacterial culture might have a positive result, and in some cases, this could just be an incidental finding. However, this subclinical bacteriuria may only need treatment in certain situations, such as when pyelonephritis is suspected, when the patient will undergo procedures involving the urinary tract, in diabetic cats, or when Corynebacterium urealyticum is isolated. Outside of those situations, no treatment is recommended in the absence of clinical signs. Although empirical therapy is discouraged, there will be cases that need to start on antibiotics while waiting for the laboratory results. For these cases, first-line antibiotics are recommended. I emphasize again the information we can get from the microscope for this. Also, therapy should be holistic, providing pain relief when needed, as well as environmental modification if necessary. If anyone is interested in this topic, I strongly recommend checking the ISFM recordings or proceedings from the 2022 Congress, which include fantastic presentations by Prof. Danièlle A. Gunn-Moore, and the 2023 Congress with a great presentation on this topic by Dr. Roswitha Dorsch. Additionally, refer to the GRAM: Guidance for the Rational Use of Antimicrobials: Recommendations for Dogs and Cats (2nd ed.) by Ceva Santé Animale, and the ISCAID guidelines for the diagnosis and management of bacterial urinary tract infections in dogs and cats. I would love to hear your thoughts about this! #felinemedicine #antimicrobialstewardship #medicinafelina #Bacteriology
To view or add a comment, sign in
-
- Feline Infectious Perotinitis (FIP) - As alarming and dangerous as it sounds it has become quite ubiquitous and is now somewhat treatable with advancement and research in veterinary medicine. - A stray cat presented with severe abdominal distention was presented, having normal vitals and mild lethargy after beign disappeared for several days from home where the cat used to eat, as reported by the owner. - After physical exam we went for the, xrays, cbc, chemistry, - Abdomenocentasis, and based on our suspection the Rivalta test. - Xrays showed fluid filled abdomen with no demarcation of any abdominal organ and fluid present in the lungs with the right lung being more involved - Cbc showed mild Leucocytosis, neutrophilia and lymphopenia Chemistry was not a typical one, with normal ALB, GLOB & ALB/GLOB ratio, with increased T-Bil only. - On Abdomenocentasis, the fluid was typical gold/yellow color - Rivalta test was a positive, unfortunately we could not run a kit test. - Treatment was initiated with supportive IV fluids, antibiotics, multivitamins, liver support & the experimental drug Remdesivir@10mg/kg - A proper treatment protocol was set in place and the cat showed remarkable recovery and more than 95% of the fluid was gone after 30 days. - P. S, the cat weighed 5kg at the beginning of treatment and the cat's weight at day of discharge was 3.8kg
To view or add a comment, sign in
-
WEBINAR ANNOUNCEMENT Treating canine pyoderma in 2024 Date: August 21, 2024, at 7 p.m. (EDT) Sign up now for this live webcast at https://lnkd.in/gnx4Np4e Antimicrobial resistance is increasingly recognized as a significant global threat to public health. Prudent use of antibiotics is an integral part of best veterinary practices. During this webcast, Dr. Vincent Defalque will focus on canine superficial pyoderma, the most prevalent infection in veterinary dermatology. The discussion will include evidence-based recommendations for diagnosing and treating methicillin-resistant staphylococcal skin infections.
To view or add a comment, sign in
-
Enucleation, or the surgical removal of an eye, is performed in buffalo for several reasons: Therapeutic Reasons: 1. Severe eye infections (e.g., corneal ulcers, endophthalmitis) 2. Eye trauma or injury 3. Cancer (e.g., squamous cell carcinoma) 4. Chronic pain or discomfort 5. Blindness or vision loss Economic Reasons: 1. Reduced productivity due to vision loss 2. Decreased milk production (in dairy buffalo) 3. Increased risk of accidents or injuries 4. Economic burden of prolonged veterinary care Humanitarian Reasons: 1. Relief from suffering and pain 2. Prevention of further complications 3. Improvement of animal welfare Common Indications: 1. Corneal ulcers 2. Cataracts 3. Glaucoma 4. Eye tumors 5. Severe conjunctivitis Surgical Procedure: 1. General anesthesia 2. Surgical preparation of the eye area 3. Enucleation of the affected eye 4. Closure of the surgical site Post-Operative Care: 1. Pain management 2. Antibiotic therapy 3. Monitoring for complications 4. Follow-up examinations Benefits: 1. Relief from pain and discomfort 2. Prevention of further complications 3. Improved animal welfare 4. Reduced economic losses 5. Enhanced quality of life Important Considerations: 1. Consult a veterinarian for proper diagnosis and treatment. 2. Enucleation should only be performed by a trained veterinary surgeon. 3. Post-operative care is crucial for a successful outcome. Enucleation in buffalo is a serious surgical procedure that should only be performed when necessary, under the guidance of a qualified veterinarian.
To view or add a comment, sign in